1. An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma
   Mitsuro Kanda et al, 2017, Oncotarget CrossRef
2. Intrahepatic recurrence of hepatocellular carcinoma after resection: an update
   Maria Tampaki et al, 2021, Clinical Journal of Gastroenterology CrossRef
3. HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma
   Feng Xue et al, 2015, Journal of Translational Medicine CrossRef
4. Expression and Prognostic Value of Melanoma-Associated Antigen D2 in Gliomas
   Jun Yan et al, 2022, Brain Sciences CrossRef
5. Effects of cross-fostering and developmental exposure to mixtures of environmental contaminants on hepatic gene expression in prepubertal 21 days old and adult male Sprague-Dawley rats
   D. Desaulniers et al, 2019, Journal of Toxicology and Environmental Health, Part A CrossRef
6. Search for useful biomarkers in hepatocellular carcinoma, tumor factors and background liver factors
   Dai Shimizu et al, 2017, Oncology Reports CrossRef
7. Melanoma antigen-D2 controls cell cycle progression and modulates the DNA damage response
   Charlotte Trussart et al, 2018, Biochemical Pharmacology CrossRef
8. A comprehensive analysis of the MAGE family as prognostic and diagnostic markers for hepatocellular carcinoma
   Rong Li et al, 2020, Genomics CrossRef
9. A novel dual‐marker expression panel for easy and accurate risk stratification of patients with gastric cancer
   Mitsuro Kanda et al, 2018, Cancer Medicine CrossRef
10. Melanoma antigen-D2: A nucleolar protein undergoing delocalization during cell cycle and after cellular stress
    Céline Pirlot et al, 2016, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
11. Prognostic roles of MAGE family�members in breast cancer based on KM‑Plotter Data
    Binghan Jia et al, 2019, Oncology Letters CrossRef
12. MAGED2 controls vasopressin-induced aquaporin-2 expression in collecting duct cells
    Björn Reusch et al, 2022, Journal of Proteomics CrossRef
13. Proteomic Analysis Revealed the Potential Role of MAGE-D2 in the Therapeutic Targeting of Triple-Negative Breast Cancer
    Xiaoyu Shi et al, 2024, Molecular & Cellular Proteomics CrossRef
14. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma
    Mitsuro Kanda, 2015, World Journal of Gastroenterology CrossRef
15. MAGE-A11 expression contributes to cisplatin resistance in head and neck cancer
    Stefan Hartmann et al, 2018, Clinical Oral Investigations CrossRef
16. Deletion of mdig enhances H3K36me3 and metastatic potential of the triple negative breast cancer cells
    Chitra Thakur et al, 2022, iScience CrossRef
17. Validation and ranking of seven staging systems of hepatocellular carcinoma
    Zhan-Hong Chen et al, 2017, Oncology Letters CrossRef